Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy

Overview of attention for article published in Nature Communications, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

news: 2 news outlets
twitter: 7 X users

patent: 4 patents
facebook: 1 Facebook page

Readers on

mendeley: 38 Mendeley

So far, Altmetric has seen 2 news stories from 2 outlets.

Cancer vaccine could be effective way to overcome treatment resistance

MedicalXpress, 02 Sep 2021

Fig. 1: CSDE1 is a positive modulator of VSV replication. A Hep3B cells were transfected with no siRNA, Negative control siRNA…

News A Vaccine To Prevent Cancer Evolution Scientists have developed a cancer vaccine that in mice was shown to trigger the immune system to destroy treatment-resistant tumor cells.

Technology Networks, 02 Sep 2021

A cancer vaccine could be an effective way to prevent cancer from evolving and becoming resistant to treatment, new research…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.